Pfizer's research showed the younger children should get a third of the normal dose given to older recipients.
Pfizer announced Thursday that it had submitted its COVID-19 vaccine for children between five and 11 years old to the U.S. Food and Drug Administration for approval, the Associated Press reported. One significant change with the young age group's shot is that it uses lesser doses compared to those given to older populations.
Pfizer said that its research demonstrated that younger kids should be given a third of the dose given to everyone else, the AP reported. Despite the difference in dosage, the younger children were able to develop levels of virus-fighting antibodies that were just as strong and effective as those seen in teens and young adults who received the typical dose of the vaccine.
If regulators approve the vaccine for children, rollout of the shots could begin within weeks, according to the AP. The availability of the vaccine could serve as a huge relief for parents who worried about the safety of children younger than 12 who didn't have the opportunity to get inoculated, but still had to attend school as COVID infections continue to surge across the country.
While kids are at lower risk of severe illness or death than older people, COVID-19 does sometimes kill children and cases in youngsters have skyrocketed as the extra-contagious Delta variant has swept through the country "It makes me very happy that I am helping other kids get the vaccine," said Sebastian Prybol, 8, of Raleigh, North Carolina. He is enrolled in
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Pfizer seeks FDA authorization of Covid-19 vaccine for children ages 5 to 11Pfizer and BioNTech said Thursday they are seeking US Food and Drug Administration emergency use authorization from for their Covid-19 vaccine for children ages 5 to 11.
Baca lebih lajut »
Pfizer, BioNTech ask FDA to authorize Covid-19 vaccine for kids 5-11The filing could clear the way for roughly 28 million children in the United States to be vaccinated against the virus, beginning in a matter of weeks.
Baca lebih lajut »
Pfizer asks FDA to authorize its COVID-19 vaccine for kids ages 5-11Pfizer said the request 'is an important step in our ongoing effort against COVID19.'
Baca lebih lajut »
Pfizer asks US to allow COVID shots for kids ages 5 to 11Pfizer asked the U.S. government Thursday to allow use of its COVID-19 vaccine in children ages 5 to 11 -- and if regulators agree, shots could begin within a matter of weeks. Many parents and pediatricians are clamoring for protection for children younger than 12, today’s age cutoff for the vaccine made by Pfizer and its German partner BioNTech. Not only can youngsters sometimes get seriously ill, but keeping them in school can be a challenge with the coronavirus still raging in poorly vaccinated communities.
Baca lebih lajut »
Pfizer Asks US To Allow COVID Shots For Kids Ages 5 To 11Pfizer is asking the U.S. government to allow use of its COVID-19 vaccine in children ages 5 to 11.
Baca lebih lajut »